
China’s state-backed blockchain operator is set for its major international debut, as the Beijing government makes the still-controversial technology one of its priorities against a background of increased turmoil for this fast-growing industry, as reported by CNBC.
China’s state-owned company, the blockchain-based Service Network (BSN), will serve as a “one-stop shop” to enable blockchain applications in the cloud, a process that can be costly and time-consuming for new companies which BSN aims to make this easier.
With its international expansion, the company is believed to be looking forward to linking various blockchains together to aid businesses in deploying the technology and boosting their flexibility online, particularly relating to their
Red Date Technology, a Hong Kong based start-up, is one of the founding members of BSN. The company will soon launch a project called BSN Spartan Network in August, which will be available overseas, according to BSN’s CEO Yifan He.
Bitcoin, the world’s most famous cryptocurrency, helped blockchain reach its popularity, and over time it has expanded into a system of shared ledgers that can be made public and accessible for everyone, or it can be private, where specific members can only use and modify the bitcoin.
It is worth noting that bitcoin is a perfect example of a public blockchain. But the catch is, BSN’s blockchain networks are not working with any existing cryptocurrencies since China has cracked down on digital coins.
Featured News
Meta Begins Defense After FTC Concludes Case in Landmark Antitrust Trial
May 15, 2025 by
CPI
UK Data Bill Still No Closer to Passage As Parliamentary ‘Ping-Pong’ Drags On
May 15, 2025 by
CPI
Regeneron Pharmaceuticals Awarded $271.2M in Damages Against Amgen
May 15, 2025 by
CPI
FTC Chair Proposes 15% Staff Reduction Amid Budget Constraints
May 15, 2025 by
CPI
UK Urges Antitrust Watchdog to Prioritize Growth and Clarity in Business Regulation
May 15, 2025 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Healthcare Antitrust
May 14, 2025 by
CPI
Healthcare & Antitrust: What to Expect in the New Trump Administration
May 14, 2025 by
Nana Wilberforce, John W O'Toole & Sarah Pugh
Patent Gaming and Disparagement: Commission Fines Teva For Improperly Protecting Its Blockbuster Medicine
May 14, 2025 by
Blaž Višnar, Boris Andrejaš, Apostolos Baltzopoulos, Rieke Kaup, Laura Nistor & Gianluca Vassallo
Strategic Alliances in the Pharma Sector: An EU Competition Law Perspective
May 14, 2025 by
Christian Ritz & Benedikt Weiss
Monopsony Power in the Hospital Labor Market
May 14, 2025 by
Kevin E. Pflum & Christian Salas